KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$1.5 billion.

  • Bristol Myers Squibb's Cash from Financing Activities rose 6131.88% to -$1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 billion, marking a year-over-year decrease of 17705.53%. This contributed to the annual value of $5.1 billion for FY2024, which is 15444.99% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Cash from Financing Activities of -$1.5 billion as of Q3 2025, which was up 6131.88% from -$1.8 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Cash from Financing Activities high stood at $14.6 billion for Q1 2024, and its period low was -$7.3 billion during Q1 2021.
  • Its 5-year average for Cash from Financing Activities is -$2.2 billion, with a median of -$3.2 billion in 2021.
  • As far as peak fluctuations go, Bristol Myers Squibb's Cash from Financing Activities crashed by 59212.52% in 2021, and later soared by 58013.11% in 2024.
  • Bristol Myers Squibb's Cash from Financing Activities (Quarter) stood at -$4.0 billion in 2021, then grew by 18.17% to -$3.2 billion in 2022, then skyrocketed by 129.79% to $967.0 million in 2023, then plummeted by 269.8% to -$1.6 billion in 2024, then increased by 9.26% to -$1.5 billion in 2025.
  • Its last three reported values are -$1.5 billion in Q3 2025, -$1.8 billion for Q2 2025, and -$993.0 million during Q1 2025.